Cantitate/Preț
Produs
Total produse
Vezi coșul
EU Pharmaceutical Regulation de Govin Permanand

EU Pharmaceutical Regulation: European Policy Studies Series

Autor Govin Permanand
en Limba Engleză Hardback – 22 mar 2006
This book provides an analysis of European Union pharmaceutical regulation from a policy-making perspective. The focus is on how the often conflicting agendas of the pharmaceutical industry, the EU member states, the European Commission, and consumer interests are reconciled within the context of regulatory outcomes having to serve public health, healthcare and industrial policy needs within the single market.

Breaking with more traditional approaches which stress the economic determinants of pharmaceutical policy, different strands of public policy analysis, regulatory and European integration and policy-making theories are invoked in developing a new conceptual approach to frame the analysis. In-depth case-studies in three key policy areas: patent protection, market authorisation, and pricing and reimbursement, provide substantive support.

In providing a unique perspective on how and why EU pharmaceutical policy is made, the book will be of interest to academics, students and policy-practitioners interested in EU policy-making, regulation and public policy analysis.

Citește tot Restrânge

Preț: 52913 lei

Preț vechi: 65763 lei
-20% Nou

Puncte Express: 794
Preț estimativ în valută:
10125€ • 10693$ • 8426£

Carte indisponibilă temporar


Wish list
Gift list
Am citit!
Adaugă în listă
Doresc să fiu notificat când acest titlu va fi disponibil:
Trimite
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780719072727
ISBN-10: 0719072727
Pagini: 264
Ilustrații: Illustrations
Dimensiuni: 237 x 163 x 24 mm
Greutate: 0.54 kg
Ediția:annotated ed.
Editura: MANCHESTER UNIVERSITY PRESS
Seria European Policy Studies Series

Locul publicării:United Kingdom

Cuprins

1. EU pharmaceutical policy: towards an understanding of the issues 2. Regulating the European medicines sector 3. Theorising the development of community competence in pharmaceuticals 4. Networks and the 'politics of policy' 5. 'Client politics': the Supplementary Protection Certificate 6. 'Entrepreneurial politics': the European Medicines Agency 7. 'Majoritarian politics': the pricing and reimbursement of medicines in the EU 8. Conclusions

Notă biografică

Govin Permanand is Research Fellow at LSE Health and Social Care, London School of Economics and Political Science

Descriere

This book provides a unique look at the political dynamics of how EU pharmaceutical policy is made within the context of having to serve public health, healthcare and industrial policy needs within the single market. Its scope covers public policy analysis, EU regulation and policy-making theories.